Helius Medical Technologies, Inc. financial data

Symbol
HSDT on Nasdaq, HSDTW on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
642 Newtown Yardley Road, Newtown, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 315 % -47.1%
Quick Ratio 41.4 % +27%
Debt-to-equity 80 % -48.9%
Return On Equity -356 % -61.1%
Return On Assets -198 % -130%
Operating Margin -2.67K % -38.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.13M shares +591%
Common Stock, Shares, Outstanding 3.73M shares +422%
Entity Public Float 3.09M USD -41.2%
Common Stock, Value, Issued 4K USD +300%
Weighted Average Number of Shares Outstanding, Basic 2.71M shares +346%
Weighted Average Number of Shares Outstanding, Diluted 2.71M shares +346%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 520K USD -19.3%
Revenue from Contract with Customer, Excluding Assessed Tax 476K USD -21.3%
Research and Development Expense 3.66M USD +24.4%
Operating Income (Loss) -13.9M USD -11.9%
Nonoperating Income (Expense) 2.16M USD -39.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.7M USD -32.7%
Net Income (Loss) Attributable to Parent -11.7M USD -32.7%
Earnings Per Share, Basic -4.33 USD/shares +70.3%
Earnings Per Share, Diluted -4.33 USD/shares +70.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.09M USD -79%
Accounts Receivable, after Allowance for Credit Loss, Current 70K USD -40.2%
Inventory, Net 1.04M USD +127%
Assets, Current 3.42M USD -54%
Property, Plant and Equipment, Net 107K USD -39.9%
Operating Lease, Right-of-Use Asset 11K USD -78.8%
Intangible Assets, Net (Excluding Goodwill) 2K USD -93.5%
Assets 3.54M USD -54%
Accounts Payable, Current 873K USD +64.4%
Liabilities, Current 2.16M USD +15.1%
Operating Lease, Liability, Noncurrent 12K USD -78.6%
Liabilities 2.48M USD -53.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 333K USD
Retained Earnings (Accumulated Deficit) -172M USD -7.34%
Stockholders' Equity Attributable to Parent 1.06M USD -54.9%
Liabilities and Equity 3.54M USD -54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3M USD +5.93%
Net Cash Provided by (Used in) Financing Activities 1.46M USD
Net Cash Provided by (Used in) Investing Activities -5K USD +73.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 3.73M shares +422%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.54M USD +51.9%
Deferred Tax Assets, Valuation Allowance 41.1M USD +9.33%
Deferred Tax Assets, Gross 41.1M USD +9.24%
Operating Lease, Liability 12K USD -78.9%
Depreciation 9K USD -25%
Payments to Acquire Property, Plant, and Equipment 5K USD -73.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.7M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid 12K USD -79.3%
Property, Plant and Equipment, Gross 502K USD -6.52%
Operating Lease, Liability, Current 12K USD -73.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 12K USD -73.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 32.6M USD +6.5%
Amortization of Intangible Assets 24K USD -79.5%
Share-based Payment Arrangement, Expense 2.52M USD +54.8%